Myelosuppression is a condition where bone marrow activity is decreased, resulting in reduced production of blood cells, which can lead to anemia, increased risk of infection, and bleeding complications. It is a common side effect of chemotherapy and certain medications, necessitating careful monitoring and management to mitigate adverse effects on patients' health.